The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause

Journal of Supportive Oncology

Volumn 4, Issue 6, 2006, Pages 295-298

  Tham, Yee Lu ^a   Sexton, Krystal ^a   Weiss, Heidi L ^a   Elledge, Richard M ^a   Friedman, Lois C ^a   Kramer, Rita M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CALCIUM; CYCLOPHOSPHAMIDE; DOXORUBICIN; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ARTICLE; BONE DENSITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EARLY MENOPAUSE; FEMALE; HIGH RISK PATIENT; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; WOMEN'S HEALTH;

ADULT; ANTINEOPLASTIC AGENTS; BONE DENSITY; BREAST NEOPLASMS; CALCIUM, DIETARY; EXERCISE; FEMALE; GUIDELINE ADHERENCE; HUMANS; MENOPAUSE, PREMATURE; OSTEOPOROSIS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL;

EID: 33747003831     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. National Comprehensive Cancer Network Breast Cancer Panel. Clinical Practice Guidelines in Oncology. Breast cancer - Version 2.2006. Available at: http://www.nccn.org/professionals/physician_gis/PDF/breast.pdf Accessed March 28, 2006.
3. Partridge AH, Burstein HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr 2001;30:135-142.
4. Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women:reproductive and late health effects of treatment. J Clin Oncol 2003;21:4184-4193.
5. Goodwin PJ, Ennis M, Pritchard KI, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 1999;17:120-129.
6. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
7. Hillner BE, Ingle JN, Berenson JR, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol 2000;18:1378-1391.
8. Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003;21:4042-4057.
9. Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Osteoporosis Methodology Group; The Osteoporosis Research Advisory Group. Endocr Rev 2002;23:552-559.
10. Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Osteoporosis Methodology Group; The Osteoporosis Research Advisory Group. Endocr Rev 2002;23:560-569.
11. Taaffe DR, Duret C, Wheeler S, Marcus R. Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults. J Am Geriatr Soc 1999;47:1208-1214.
12. Rosenberg R, Levy-Schwartz R. Breast cancer in women younger than 40 years. Int J Fertil Womens Med 2003;48:200-205.
13. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526-528.
14. Edwards BJ, Brooks ER, Langman CB. Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach. Gend Med 2004;1:70-85.
15. Schrager S, Kausch T, Bobula JA. Osteoporosis risk assessment by family practice faculty and residents: a chart review. WMJ 1999;98:34-36.
16. Solomon DH, Brookhart MA, Gandhi TK, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 2004;117:919-924.
17. Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 1999;79:1179-1181.
18. Chen Z, Maricic M, Bassford TL, et al. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:552-558.
19. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001;19:3306-3311.
20. Vehmanen L, Saarto T, Elomaa I, Makela P, Valimaki M, Blomqvist C. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients: the effect of adjuvant clodronate treatment. Eur J Cancer 2001;37:2373-2378.
21. Lester J, Dodwell D, McCloskey E, Coleman R. The causes and treatment of bone loss associated with carcinoma of the breast. Cancer Treat Rev 2005;31:115-142.
22. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388.
23. Puleo E, Zapka JG, Goins KV, et al. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof 2005;28:310-327.
24. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 2003;12:1182-1187.
25. Martin LM, Leff M, Calonge N, Garrett C, Nelson DE. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000;18:215-218.